Pharma & Biotech
Acasti Pharma eyeing FDA meeting as it continues to advance heart disease candidate CaPre
Imugene presents HER2 immuno-oncology vaccines success at ESMO ahead of 2020 studies
Duos Technologies moves full steam ahead with its intelligent technologies
Only registered members can use this feature.
Copyright © Proactive Investors 2019.
All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC.